Purpose A high plasma level of either fibrinogen or d-dimer has been shown to correlate
with a poor prognosis in patients with surgically resected non-small-cell lung cancer …

Previous studies have suggested an association between preoperative plasma fibrinogen
and D-dimer levels and prognosis in patients with non-small cell lung cancer (NSCLC) who …

Background The number of surgical procedures has increased among patients with early‐
stage lung cancer. If the poor prognostic factors for stage I non‐small cell lung cancer …

The purpose of the present study was to evaluate the prognostic value of preoperative
coagulation factor levels (including fibrinogen and D‑dimer) and inflammatory indicators in …

Background The relationships between coagulation factors and non‐small cell lung cancer
(NSCLC) prognosis have been intensively studied. However, no previous study has …

Serum fibrinogen converted to insoluble fibrin by activated thrombin, plays an important role
in the coagulation system. Increased fibrinogen considerably influences cancer cell growth …

Objective This study was undertaken to assess the potential value of preoperative blood
components as prognostic markers of outcome after lung cancer resection, and hence their …

Purpose Elevated plasma fibrinogen and D-dimer levels indicate activation of hemostasis
and fibrinolysis, and this activation is required for tumor angiogenesis, metastasis, and …

Many researchers have shown that pretreatment plasma fibrinogen levels are closely
correlated with the prognosis of patients with lung cancer (LC). In this study, we thus …

Background and aims D-dimer is a stable end product of fibrin degradation that is
associated with advanced tumor stage and poor prognosis in lung cancer patients. Venous …